- Investing Ideas
- /
- Global Undervalued Stocks Based On Cash Flows
Global Undervalued Stocks Based On Cash Flows
Results
898
0 new
Companies with promising cash flow potential yet trading below their fair value, as determined by SWS DCF valuation, signaling opportunity for value-oriented investors.
898 companies
| Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | Industry | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
8508 | JP¥520.00 | 4.4% | 9.7% | JP¥69.1b | n/a | PE29.8x | E35.9% | 2.7% | Diversified Financials | ||
IEL | AU$13.17 | 4.3% | -31.7% | AU$3.7b | AU$18.17 | PE27.6x | E13.8% | 2.6% | Consumer Services | ||
DATA | UK£1.78 | -1.9% | -10.8% | UK£1.4b | UK£2.66 | PE42.6x | E25.8% | 2.6% | Commercial Services | ||
ABDL | ₹394.40 | -2.7% | n/a | ₹110.3b | ₹466.67 | PE96.9x | E35.6% | n/a | Food, Beverage & Tobacco | ||
BUFAB | SEK 464.20 | 2.0% | 24.7% | SEK 17.4b | SEK 467.50 | PE34.4x | E20.8% | 1.1% | Capital Goods | ||
KXS | CA$170.00 | -3.8% | 3.5% | CA$4.8b | CA$198.62 | PE163x | E42.9% | n/a | Software | ||
688046 | CN¥13.06 | -3.1% | 2.8% | CN¥5.3b | CN¥14.00 | PE38.3x | E24.2% | 0.5% | Pharmaceuticals & Biotech | ||
ARRY | US$7.15 | 12.0% | -46.0% | US$1.0b | US$10.10 | PS1.1x | E65.1% | n/a | Capital Goods | ||
1813 | JP¥2,192.00 | 2.4% | -5.5% | JP¥33.1b | JP¥3,100.00 | PE25.3x | E35.1% | 2.7% | Capital Goods | ||
VGL | NZ$3.10 | -4.3% | 93.8% | NZ$736.8m | NZ$3.08 | PS5.2x | E47.8% | 0% | Software | ||
CDR | CA$1.83 | 1.7% | 4.0% | CA$118.7m | CA$4.85 | PS3.3x | E145.8% | n/a | Energy | ||
NISB | NOK 100.02 | -3.8% | -8.2% | NOK 112.9m | NOK 104.00 | PB0.2x | E29.8% | 5.7% | Banks | ||
S32 | AU$3.36 | -4.8% | 2.1% | AU$15.1b | AU$3.81 | PS1.7x | E52.0% | 1.7% | Materials | ||
A248070 | ₩18,950.00 | 1.8% | -29.7% | ₩912.2b | ₩31,625.00 | PE20.5x | E50.0% | n/a | Tech | ||
1818 | HK$12.14 | -1.0% | 65.2% | HK$41.3b | HK$16.58 | PE32x | E38.6% | 0.4% | Materials | ||
TOU | CA$67.31 | -2.4% | 16.3% | CA$25.2b | CA$79.20 | PE16.2x | E28.1% | 5.8% | Energy | ||
6613 | JP¥302.00 | -0.7% | -44.5% | JP¥12.6b | JP¥560.00 | PS10.8x | E86.7% | n/a | Semiconductors | ||
7373 | JP¥1,827.00 | 4.9% | -14.2% | JP¥27.9b | JP¥4,700.00 | PE18.7x | E23.1% | 1.6% | Commercial Services | ||
PRVA | US$22.54 | -1.7% | 9.8% | US$2.7b | US$26.00 | PE210.9x | E34.2% | n/a | Healthcare | ||
3649 | JP¥925.00 | 3.2% | -11.0% | JP¥23.7b | n/a | PE17.9x | E14.9% | 1.6% | Healthcare | ||
300702 | CN¥17.32 | 2.7% | 4.7% | CN¥6.0b | CN¥22.42 | PE136.4x | E71.4% | 0.3% | Pharmaceuticals & Biotech | ||
DUKE | UK£0.29 | -4.3% | -10.1% | UK£145.6m | UK£0.46 | PE14.3x | E29.7% | 9.7% | Diversified Financials | ||
OTB | UK£2.51 | -1.2% | 70.3% | UK£416.7m | UK£2.86 | PE20x | E20.7% | 1.2% | Consumer Services | ||
1164 | HK$1.53 | -18.2% | -21.9% | HK$11.6b | HK$2.10 | PE27x | E39.2% | 0.4% | Energy |